ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

4 Dividend Aristocrats Trading at a Discount

metallic pfizer logo mounted on wall

The first quarter of the year was a success for investors. The overall market (NYSE: SPY) surged nearly 10%, fueled by robust economic indicators, optimism, and hype surrounding AI. The semiconductor sector led the charge, riding a wave of demand spurred by the AI revolution, with gains nearing 28%

However, as the quarter progressed, attention shifted towards traditionally defensive sectors like Utilities, Financials, Industrials, and Consumer Staples. Surprisingly, these sectors caught up with the broader market, and some even outperformed it, signaling a subtle yet significant move towards risk-off assets.

Against this backdrop, dividend aristocrats—companies with a history of consistently increasing dividends—emerge as potential havens for stability and income. As market sentiment hints toward defensive stances, identifying undervalued stocks with attractive dividend yields becomes beneficial.

So, let's explore four dividend aristocrats positioned at fair values or discounts. They are poised to withstand market volatility while offering investors a reliable income stream. 

Four Dividend Aristocrats Trading Near Fair Value

Pfizer (NYSE: PFE)

Pfizer, a prominent U.S.-based multinational biotech corporation valued at $157 billion, boasts a remarkable record of increasing dividends for fourteen consecutive years. With a current dividend yield of 6.05%, significantly surpassing the average, and a three-year annualized dividend growth rate of 12.89%, Pfizer stands out as an attractive option for income-oriented investors. 

Despite experiencing a modest 3% decline year-to-date, the stock is trading close to significant multi-year support levels. Recent price action indicates a potential bottom near $27, suggesting a critical juncture for the stock's short-term trajectory. Analysts have placed a consensus rating on Pfizer as a Hold, with a target price of $36.88, signaling a notable upside potential of 32.88% from current levels. 

Altria Group (NYSE: MO)

MO is a cornerstone of the U.S. tobacco industry and one of its leading players. It boasts a fifty-five-year track record of dividend increases. Altria is an attractive choice for income-seeking investors, with an impressive dividend yield of 8.99% and a solid three-year annualized dividend growth rate of 4.14%. 

The tobacco giant's shares have demonstrated resilience, posting a year-to-date gain of over 8%, mirroring the broader market's performance. Noteworthy is Altria's appealing price-to-earnings ratio (P/E) of 9.54, coupled with a projected earnings growth rate of 4.13% for the full year. Analyst sentiment on Altria remains balanced, with a Hold rating based on four analyst ratings. The consensus price target of $46.82 suggests a potential upside of 7.34% from current levels, highlighting the stock's appeal to investors eyeing income and modest capital appreciation.

Ford (NYSE: F)

Ford, the renowned U.S. automotive behemoth established in 1903, commands a market capitalization of $52 billion and currently sports a price-to-earnings ratio (P/E) of 12.29. With an impressive dividend yield of 4.52%, Ford remains an attractive option for income-oriented investors. Bolstering its appeal is a commendable three-year annualized dividend growth rate of 58%.

Despite enduring a volatile market environment, Ford has demonstrated resilience, posting a year-to-date increase of almost 9%, closely tracking the broader market's performance. Based on thirteen analyst evaluations, the stock has a Hold rating, with a consensus price target forecasting nearly 4% upside potential.

AT&T (NYSE: T)

T, recognized as the world's largest telecommunications company, boasts a substantial market capitalization of $125 billion. With an impressive dividend yield of 6.3% and an annual dividend payment of $1.11, AT&T stands out as a reliable income generator in a competitive market landscape. 

Notably, the stock presents an attractive proposition for value investors, with a modest price-to-earnings (P/E) ratio of 8.98. Despite a relatively modest year-to-date gain of 4.98%, analysts remain bullish on AT&T's prospects. Garnering positive sentiment from fifteen analyst ratings, the stock holds a moderate buy rating, with a consensus price target projecting a promising 22% upside potential. As investors seek stability and income in an evolving market environment, AT&T's robust dividend yield and favorable valuation make it an appealing choice for those looking to balance income and growth in their portfolios.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.21
-5.73 (-2.62%)
AAPL  257.46
-2.83 (-1.09%)
AMD  192.43
-7.02 (-3.52%)
BAC  48.64
-0.89 (-1.80%)
GOOG  298.30
-2.61 (-0.87%)
META  644.86
-15.71 (-2.38%)
MSFT  408.96
-1.72 (-0.42%)
NVDA  177.82
-5.52 (-3.01%)
ORCL  152.96
-1.83 (-1.18%)
TSLA  396.73
-8.82 (-2.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.